We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Taula Rodona Venture Summit Vall d'Hebron 2024
Presentació Venture Summit VH
Taula Rodona Venture Summit VH
El VHIR organitza la primera trobada entre emprenedors i l’ecosistema inversor.
The first Vall d'Hebron Ventures Summit took place on May 6th. It is a meeting organised by VHIR to bring together its spin-offs and their corresponding investors, with the aim of building a community among them. Although many already know each other because they have met at other events, VHIR aims to be the link that reinforces the ties and provides visibility to all the stakeholders.
On this event, fifteen of our spin-offs were briefly presented: Imidomics (Sara Marsal, CMO), Bsure Medical (Menno Marien), Mimark Diagnostics (Marina Rigau), Endolipid Therapeutics & Endolipid Derma (David Martínez-Selva, CSO), Tensor Medical (Sergi Valverde), Frontwave (Cristina Duran), Nora Health (Ariadna Oroval), Abcdx (Jean-Charles Sanchez), Manina Medtech (Mónica Rodríguez, vídeo), D-Sight (Carla Maté), heecap (Laura Lizama), Ysotope theranostics (Carlos Langeberg), Artis Development (Raul Guerra), Trackyourmed (Oriol Bestard). Thus, the attendees were able to get an overview of what the entrepreneurs are working on and the current stage they are at.
The round panel ‘The 3 perspectives of an investment round’ exposed the three visions of this stage which often generates conflict between investors and entrepreneurs. Participants included Marina Rigau, CEO and co-founder of MiMARK, Laura Rodríguez, investor at Invivo Partners, and Antoni Rosselló, lawyer at RCD. In fact, lawyers also play a very significant role mediating and supporting during all the stages of the investment rounds.
In addition, other investors were invited in order they could learn about new opportunities in this community. The event was also opened to all the Campus Vall d'Hebron researchers in order to encourage entrepreneurialism.
This meeting was created to become an annual event of reference in the sector to facilitate the recruitment of both national as well as international investors of and for our companies. According to Rafael Navajo, Director of Innovation and Business Development at the VHIR, "it is a unique opportunity to create a network of connections between different environments, which will help us maintain our position as a reference centre in innovation management. It also allows us to continue positively impacting patient society'.
Una trobada per reunir a les seves spin-off i els seus corresponents inversors amb l’objectiu de crear una comunitat entre ells.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.